GlassScriptPhysician profile
Erin Robyn Robles-Sherman
NPI 1649561176
$1,259.61
in general payments reported to CMS, 2019-2025
12 companies · $319 in 2025
The $319 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $172 · 2021: $40.82 · 2023: $126 · 2024: $169 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $613.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $377.94 | 2019-2024 | Augment Injectable, Hoffmann |
| Medtronic, INC. | $169.77 | 2025 | Inceptiv |
| Lifenet Health | $149.11 | 2025 | Theragenesis Wound Matrix |
| Biopro, INC. | $122.55 | 2019-2020 | |
| Organogenesis INC. | $114.95 | 2019 | |
| Horizon Therapeutics Plc | $109.76 | 2019 | |
| Orthofix Medical, INC. | $88.83 | 2019 | |
| Supreme Orthopedic Systems, LLC | $36.03 | 2023-2024 | |
| Wright Medical Technology, INC. | $33.84 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $20.82 | 2021 | |
| Ossio INC | $20.00 | 2021 | |
| Zyla Life Sciences, INC. | $16.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Robles-Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.